Spots Global Cancer Trial Database for localized osteosarcoma
Every month we try and update this database with for localized osteosarcoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma | NCT00002539 | Sarcoma | filgrastim cisplatin doxorubicin hyd... conventional su... | - 40 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Biomarkers in Predicting Response to Chemotherapy in Samples From Young Patients With Osteosarcoma | NCT01374672 | Localized Osteo... Metastatic Oste... Osteoblastic Os... Recurrent Osteo... | laboratory biom... | 10 Years - 20 Years | Children's Oncology Group | |
| Combination Chemotherapy in Treating Patients Undergoing Surgery for Newly Diagnosed High-Grade Osteosarcoma | NCT00645632 | Sarcoma | cisplatin doxorubicin hyd... ifosfamide methotrexate adjuvant therap... neoadjuvant the... therapeutic con... | - | Mayo Clinic | |
| Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic Osteosarcoma | NCT00003937 | Cardiac Toxicit... Sarcoma | cisplatin dexrazoxane hyd... doxorubicin hyd... etoposide ifosfamide methotrexate conventional su... | - 30 Years | Children's Oncology Group | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma | NCT01062438 | Sarcoma | DNA analysis RNA analysis gene expression... gene rearrangem... mutation analys... laboratory biom... | - | Children's Oncology Group | |
| A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma | NCT05691478 | High Grade Oste... Localized Osteo... Metastatic Oste... Secondary Osteo... | Bone Scan Cabozantinib S-... Cisplatin Computed Tomogr... Doxorubicin Hyd... Magnetic Resona... Methotrexate Surgical Proced... X-Ray Imaging | - 40 Years | National Cancer Institute (NCI) | |
| Samarium Sm 153 and Stem Cell Transplant Followed By Radiation Therapy Patients With Osteosarcoma | NCT00245011 | Sarcoma | filgrastim ifosfamide peripheral bloo... Sm-EDTMP (low d... sm-EDTMP (highe... | 13 Years - 50 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Sorafenib and Ifosfamide in Treating Patients With High-Grade Soft Tissue Sarcoma or Bone Sarcoma That Can Be Removed by Surgery | NCT00880542 | Sarcoma | sorafenib Ifosfamide | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma | NCT01062438 | Sarcoma | DNA analysis RNA analysis gene expression... gene rearrangem... mutation analys... laboratory biom... | - | Children's Oncology Group | |
| Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma | NCT00026416 | Sarcoma | recombinant int... thalidomide adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Cyproheptadine in Preventing Weight Loss in Children Receiving Chemotherapy for Cancer | NCT01132547 | Cancer | cyproheptadine ... placebo | 2 Years - 21 Years | University of South Florida | |
| Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma | NCT01062438 | Sarcoma | DNA analysis RNA analysis gene expression... gene rearrangem... mutation analys... laboratory biom... | - | Children's Oncology Group | |
| Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With Osteosarcoma | NCT00002539 | Sarcoma | filgrastim cisplatin doxorubicin hyd... conventional su... | - 40 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy | NCT00716976 | Brain Tumor Central Nervous... Childhood Germ ... Extragonadal Ge... Liver Cancer Neuroblastoma Ototoxicity Ovarian Cancer Sarcoma | sodium thiosulf... examination | 1 Year - 18 Years | Children's Oncology Group | |
| Biomarker Expression in Tissue Samples From Patients With Bone Sarcomas | NCT01807052 | Localized Osteo... Metastatic Oste... Recurrent Osteo... | laboratory biom... | - 39 Years | Children's Oncology Group | |
| Interferon Alfa and Thalidomide in Treating Patients With Soft Tissue Sarcoma or Bone Sarcoma | NCT00026416 | Sarcoma | recombinant int... thalidomide adjuvant therap... | 18 Years - | National Cancer Institute (NCI) | |
| Study of Blood Samples From Patients With Osteosarcoma | NCT00954473 | Localized Osteo... Metastatic Oste... Recurrent Osteo... | laboratory biom... | - | Children's Oncology Group | |
| Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma | NCT00134030 | Localized Osteo... Metastatic Oste... | Cisplatin Doxorubicin Hyd... Etoposide Ifosfamide Methotrexate Peginterferon A... Quality-of-Life... Questionnaire A... Therapeutic Con... | 5 Years - 40 Years | Children's Oncology Group |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
